Zhejiang Jiuzhou Pharmaceutical's wholly-owned subsidiary has been recognized as a high-tech enterprise.

Zhejiang Jiuzhou Pharmaceutical (603456.SH) announced that its wholly-owned subsidiary Ruibo (Hangzhou) Medical Technology Co., Ltd. (referred to as "Ruibo Hangzhou") has obtained the certification of a high-tech enterprise. The certificate number is GR202433008949, issued on December 6, 2024, and valid for three years. According to national regulations, Ruibo Hangzhou will enjoy related tax preferential policies for high-tech enterprises for three years (2024-2026) after obtaining the certification, with a tax rate of 15% for corporate income tax.